ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 18 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,852 | -82.5% | 2,242 | -76.0% | 0.00% | -100.0% |
| Q2 2023 | $33,452 | – | 9,344 | +27382.4% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 34 | -97.4% | 0.00% | -100.0% |
| Q4 2022 | $16 | -98.4% | 1,306 | +553.0% | 0.00% | – |
| Q3 2022 | $1,000 | -88.9% | 200 | -89.2% | 0.00% | – |
| Q2 2022 | $9,000 | -95.3% | 1,847 | -91.7% | 0.00% | -100.0% |
| Q1 2022 | $192,000 | +291.8% | 22,189 | +546.2% | 0.00% | +100.0% |
| Q4 2021 | $49,000 | +226.7% | 3,434 | +393.4% | 0.00% | – |
| Q3 2021 | $15,000 | -63.4% | 696 | -77.5% | 0.00% | -100.0% |
| Q2 2021 | $41,000 | -19.6% | 3,093 | -38.3% | 0.00% | 0.0% |
| Q1 2021 | $51,000 | +5000.0% | 5,013 | +2108.4% | 0.00% | – |
| Q4 2020 | $1,000 | -92.9% | 227 | -94.5% | 0.00% | -100.0% |
| Q2 2020 | $14,000 | +27.3% | 4,104 | +10.2% | 0.00% | 0.0% |
| Q1 2020 | $11,000 | +175.0% | 3,724 | +333.5% | 0.00% | – |
| Q4 2019 | $4,000 | -93.2% | 859 | -95.4% | 0.00% | -100.0% |
| Q3 2019 | $59,000 | +1080.0% | 18,491 | +1137.7% | 0.00% | – |
| Q2 2019 | $5,000 | 0.0% | 1,494 | -0.8% | 0.00% | – |
| Q1 2019 | $5,000 | +25.0% | 1,506 | +74.9% | 0.00% | – |
| Q3 2018 | $4,000 | +100.0% | 861 | +206.4% | 0.00% | – |
| Q1 2018 | $2,000 | +100.0% | 281 | +114.5% | 0.00% | – |
| Q4 2017 | $1,000 | -75.0% | 131 | -66.7% | 0.00% | – |
| Q3 2017 | $4,000 | +300.0% | 393 | +114.8% | 0.00% | – |
| Q2 2017 | $1,000 | -66.7% | 183 | -65.2% | 0.00% | – |
| Q4 2016 | $3,000 | -70.0% | 526 | -59.0% | 0.00% | -100.0% |
| Q3 2016 | $10,000 | +233.3% | 1,284 | +221.0% | 0.00% | – |
| Q2 2016 | $3,000 | +50.0% | 400 | +14.0% | 0.00% | – |
| Q1 2016 | $2,000 | 0.0% | 351 | +32.5% | 0.00% | – |
| Q4 2015 | $2,000 | -50.0% | 265 | -57.9% | 0.00% | – |
| Q3 2015 | $4,000 | +100.0% | 630 | +55.6% | 0.00% | – |
| Q4 2014 | $2,000 | -50.0% | 405 | -8.0% | 0.00% | – |
| Q3 2014 | $4,000 | -76.5% | 440 | -76.1% | 0.00% | -100.0% |
| Q2 2014 | $17,000 | -73.0% | 1,840 | -65.7% | 0.00% | -75.0% |
| Q1 2014 | $63,000 | – | 5,359 | +26695.0% | 0.01% | – |
| Q4 2013 | $0 | -100.0% | 20 | -99.1% | 0.00% | -100.0% |
| Q3 2013 | $14,000 | +55.6% | 2,333 | +112.1% | 0.00% | +100.0% |
| Q2 2013 | $9,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 315,301 | $1,444,000 | 1.50% |
| Private Portfolio Partners LLC | 54,010 | $247,366 | 0.07% |
| Knoll Capital Management, LLC | 20,000 | $92,000 | 0.05% |
| Urban Wealth Management, LLC | 2,858 | $13,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 100,216 | $459,000 | 0.04% |
| XTX Topco Ltd | 18,174 | $83,000 | 0.03% |
| Rossmore Private Capital | 40,661 | $186,000 | 0.03% |
| Ergoteles LLC | 224,700 | $1,029,000 | 0.03% |
| ETF MANAGERS GROUP, LLC | 87,365 | $393,000 | 0.01% |
| Belvedere Trading LLC | 40,690 | $343,000 | 0.01% |